These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 27187426

  • 1. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
    Liu JY, Chen TJ, Hwang SJ.
    Int J Environ Res Public Health; 2016 May 11; 13(5):. PubMed ID: 27187426
    [Abstract] [Full Text] [Related]

  • 2. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
    Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L.
    Int J Cancer; 2001 Jun 15; 92(6):919-22. PubMed ID: 11351317
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS.
    J Natl Cancer Inst; 2001 May 16; 93(10):754-62. PubMed ID: 11353785
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L.
    Acta Oncol; 2014 Jun 16; 53(6):752-8. PubMed ID: 24460068
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct 11; 350(9084):1047-59. PubMed ID: 10213546
    [Abstract] [Full Text] [Related]

  • 7. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study.
    Ewertz M, Mellemkjaer L, Poulsen AH, Friis S, Sørensen HT, Pedersen L, McLaughlin JK, Olsen JH.
    Br J Cancer; 2005 Apr 11; 92(7):1293-7. PubMed ID: 15785751
    [Abstract] [Full Text] [Related]

  • 8. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
    Yoo TK, Han KD, Kim D, Ahn J, Park WC, Chae BJ.
    Cancer Epidemiol Biomarkers Prev; 2020 Jul 11; 29(7):1341-1347. PubMed ID: 32299849
    [Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy and cancer risks in perimenopausal women: A retrospective cohort study using a Japanese claims database.
    Inayama Y, Mizuno K, Yamaguchi K, Hamanishi J, Takeuchi M, Egawa M, Mandai M, Kawakami K.
    J Obstet Gynaecol Res; 2023 Jul 11; 49(7):1805-1814. PubMed ID: 37029559
    [Abstract] [Full Text] [Related]

  • 10. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May 11; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

  • 11. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B.
    Int J Cancer; 2004 May 01; 109(5):721-7. PubMed ID: 14999781
    [Abstract] [Full Text] [Related]

  • 12. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
    Kim S, Ko Y, Lee HJ, Lim JE.
    Breast Cancer Res Treat; 2018 Aug 01; 170(3):667-675. PubMed ID: 29713854
    [Abstract] [Full Text] [Related]

  • 13. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 14. Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.
    Salmon RJ, Ansquer Y, Asselain B, Languille O, Lesec G, Remvikos Y.
    Oncol Rep; 1999 May 15; 6(3):699-703. PubMed ID: 10203618
    [Abstract] [Full Text] [Related]

  • 15. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C, Cesana G, Contiero P, Tagliabue G, Nappi RE, Merlino L.
    Ann Oncol; 2008 Jan 15; 19(1):150-5. PubMed ID: 17785762
    [Abstract] [Full Text] [Related]

  • 16. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.
    Cancer; 2004 Jun 01; 100(11):2328-37. PubMed ID: 15160335
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy regimens and breast cancer risk(1).
    Weiss LK, Burkman RT, Cushing-Haugen KL, Voigt LF, Simon MS, Daling JR, Norman SA, Bernstein L, Ursin G, Marchbanks PA, Strom BL, Berlin JA, Weber AL, Doody DR, Wingo PA, McDonald JA, Malone KE, Folger SG, Spirtas R.
    Obstet Gynecol; 2002 Dec 01; 100(6):1148-58. PubMed ID: 12468157
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
    Jernström H, Bendahl PO, Lidfeldt J, Nerbrand C, Agardh CD, Samsioe G.
    Cancer Causes Control; 2003 Sep 01; 14(7):673-80. PubMed ID: 14575365
    [Abstract] [Full Text] [Related]

  • 19. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.
    Int J Cancer; 2005 Apr 10; 114(3):448-54. PubMed ID: 15551359
    [Abstract] [Full Text] [Related]

  • 20. A population-based cohort study of HRT use and breast cancer in southern Sweden.
    Olsson H, Bladström A, Ingvar C, Möller TR.
    Br J Cancer; 2001 Sep 01; 85(5):674-7. PubMed ID: 11531250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.